Monoamine oxidase A and B inhibitors in Parkinson's disease.
Youdim
Moussa B H
MB
Department of Pharmacology, Technion-Bruce Rappaport Faculty of Medicine, Eve Topf and NPF Neurodegenerative Diseases Centers, Rappaport Family Research Institute, Haifa, Israel.
Riederer
Peter F
PF